Company intelligence / Profile preview

Laboratorios Liomont

Mexico City, Ciudad de México / State of Mexico, Mexicoliomont.com.mx ↗

Ownership: Private
Employees: ~1400
Development stage: Commercial

Overview

Liomont has a long history of commercialized prescription and OTC products in Mexico and Latin America. The company’s pipeline includes preclinical-stage biologics for asthma and pending-stage combination drugs for pain management. It played a key role in the fill-finish process for AstraZeneca’s COVID‑19 vaccine during the pandemic. No recent clinical trial results are publicly detailed.

Therapeutic areas: PulmonologyNeurologyInfectious Diseases
Modalities: Monoclonal antibodies (mAbs)small molecules (analgesics, antibiotics, antispasmodics, antihypertensives, anti-inflammatories)combination drugs
Industry: Biotech

Drug pipeline

1 asset

LT-01

Partnerships

Oncobiologics Inc.partnership with AstraZeneca for COVID‑19 vaccine fill-finish operations

Beyond the preview

Go deeper on Laboratorios Liomont.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Laboratorios Liomont.